Recombinant Mouse NDK1 Protein，His

NDK1 (Nucleoside Diphosphate Kinase 1) is a critical enzyme involved in nucleotide metabolism, playing a key role in the regulation of intracellular nucleotide pools and energy balance. It catalyzes the conversion of nucleoside diphosphates to triphosphates, facilitating DNA and RNA synthesis, which is essential for cell proliferation and survival. Research has highlighted the significance of NDK1 in various biological processes, including cell signaling, apoptosis, and stress response. Abnormal expression or activity of NDK1 has been implicated in several diseases, including cancer, where it may contribute to tumorigenesis by enhancing cell proliferation and survival under hostile conditions. Therefore, the recombinant expression of NDK1 protein is of considerable interest for both fundamental studies and potential therapeutic applications. By producing NDK1 in a controlled laboratory environment, researchers can investigate its biochemical properties, regulatory mechanisms, and interactions with other cellular components. This foundational understanding can lead to the development of targeted therapies that modulate NDK1 activity in disease contexts, indicating its potential as a biomarker or therapeutic target in oncology and other disorders linked to nucleotide metabolism. The development of recombinant NDK1 also provides a platform for high-throughput screening of small molecules that could inhibit or enhance its enzymatic activity, further advancing our understanding of its role in cellular physiology and pathology. Overall, the study of recombinant NDK1 is not only vital for elucidating its biological functions but also holds promise for novel therapeutic strategies aimed at manipulating nucleotide metabolism in disease.